These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 9862682)
1. Coreceptor-independent T cell activation in mice expressing MHC class II molecules mutated in the CD4 binding domain. Mostaghel EA; Riberdy JM; Steeber DA; Doyle C J Immunol; 1998 Dec; 161(12):6559-66. PubMed ID: 9862682 [TBL] [Abstract][Full Text] [Related]
2. Selection and function of CD4+ T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4. Gilfillan S; Shen X; König R J Immunol; 1998 Dec; 161(12):6629-37. PubMed ID: 9862691 [TBL] [Abstract][Full Text] [Related]
3. Th cells and Th2 responses can develop in the absence of MHC class II-CD4 interactions. Wack A; Corbella P; Harker N; Roderick K; Norton T; Williams K; Williams O; Kioussis D J Immunol; 1999 Aug; 163(3):1162-9. PubMed ID: 10415010 [TBL] [Abstract][Full Text] [Related]
4. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development. Yelon D; Schaefer KL; Berg LJ J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389 [TBL] [Abstract][Full Text] [Related]
5. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules. Shen X; Niu C; König R Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721 [TBL] [Abstract][Full Text] [Related]
6. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice. Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222 [TBL] [Abstract][Full Text] [Related]
7. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death. Maroto R; Shen X; König R J Immunol; 1999 May; 162(10):5973-80. PubMed ID: 10229835 [TBL] [Abstract][Full Text] [Related]
8. Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice. Rahemtulla A; Kündig TM; Narendran A; Bachmann MF; Julius M; Paige CJ; Ohashi PS; Zinkernagel RM; Mak TW Eur J Immunol; 1994 Sep; 24(9):2213-8. PubMed ID: 7916297 [TBL] [Abstract][Full Text] [Related]
9. Regulation of memory CD4 T cell adhesion by CD4-MHC class II interaction. Metz DP; Farber DL; Konig R; Bottomly K J Immunol; 1997 Sep; 159(6):2567-73. PubMed ID: 9300674 [TBL] [Abstract][Full Text] [Related]
10. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo. Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160 [TBL] [Abstract][Full Text] [Related]
11. Post-thymic selection of peripheral CD4+ T-lymphocytes on class II major histocompatibility antigen-bearing cells. Shen X; König R Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):87-96. PubMed ID: 11292263 [TBL] [Abstract][Full Text] [Related]
12. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells. Sant AJ J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935 [TBL] [Abstract][Full Text] [Related]
13. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant. Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. Rock KL; Clark K J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907 [TBL] [Abstract][Full Text] [Related]
15. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules. Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002 [TBL] [Abstract][Full Text] [Related]
16. The level of CD4 surface protein influences T cell selection in the thymus. Frank GD; Parnes JR J Immunol; 1998 Jan; 160(2):634-42. PubMed ID: 9551897 [TBL] [Abstract][Full Text] [Related]
17. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice. Lieberman SA; Spain LM; Wang L; Berg LJ Cell Immunol; 1995 Apr; 162(1):56-67. PubMed ID: 7704911 [TBL] [Abstract][Full Text] [Related]
18. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage. Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572 [TBL] [Abstract][Full Text] [Related]
19. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition. Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152 [TBL] [Abstract][Full Text] [Related]
20. Human anti-mouse xenorecognition. Provision of noncognate interactions reveals plasticity of T cell repertoire. Batten P; Heaton T; Fuller-Espie S; Lechler RI J Immunol; 1995 Aug; 155(3):1057-65. PubMed ID: 7543511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]